ANI Pharmaceuticals Company Profile (NASDAQ:ANIP)

About ANI Pharmaceuticals

ANI Pharmaceuticals logoANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company. The Company is engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The Company's focused areas of product development include anti-cancer (oncolytics), hormones and steroids, and complex formulations. Its generic products include Esterified Estrogen with Methyltestosterone, Etodolac, Flecainide, Fluvoxamine, Hydrocortisone Enema, Methazolamide, Metoclopramide Syrup, Nimodipine, Opium Tincture, Oxycodone Oral Solution, Propafenone and Vancomycin. Its branded products include Cortenema, Lithobid, Reglan and Vancocin. It has over two pharmaceutical manufacturing facilities located in Baudette, Minnesota that are capable of producing oral solid dose products, as well as liquids and topicals, controlled substances, and potent products. Its two facilities have a combined manufacturing, packaging and laboratory capacity totaling approximately 173,000 square feet.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ANIP
  • CUSIP:
Key Metrics:
  • Previous Close: $67.21
  • 50 Day Moving Average: $62.02
  • 200 Day Moving Average: $47.90
  • Trailing P/E Ratio: 80.12
  • Foreward P/E Ratio: 15.89
  • P/E Growth: 1.06
  • Market Cap: $785.02M
  • Outstanding Shares: 11,514,000
  • Beta: 2.79
Additional Links:
Companies Related to ANI Pharmaceuticals:

Analyst Ratings

Consensus Ratings for ANI Pharmaceuticals (NASDAQ:ANIP) (?)
Ratings Breakdown: 1 Hold Rating, 4 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $65.67 (2.30% downside)

Analysts' Ratings History for ANI Pharmaceuticals (NASDAQ:ANIP)
DateFirmActionRatingPrice TargetDetails
8/5/2016GuggenheimReiterated RatingBuy$65.00 -> $80.00View Rating Details
8/5/2016Oppenheimer Holdings Inc.Boost Price TargetOutperform$65.00 -> $71.00View Rating Details
7/19/2016Citigroup Inc.UpgradeOutperform$65.00View Rating Details
6/22/2016Raymond James Financial Inc.Initiated CoverageStrong-Buy$68.00View Rating Details
5/24/2016Standpoint ResearchDowngradeBuy -> HoldView Rating Details
11/4/2015Roth CapitalReiterated RatingBuy$60.00 -> $56.00View Rating Details
(Data available from 8/24/2014 forward)


Earnings History for ANI Pharmaceuticals (NASDAQ:ANIP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2016Q216$0.77$1.11$27.63 million$31.30 millionViewN/AView Earnings Details
5/5/2016Q116$0.64$0.76$21.03 million$20.60 millionViewN/AView Earnings Details
2/23/2016Q415$0.60$0.52$18.13 million$18.04 millionViewN/AView Earnings Details
11/3/2015Q315$0.63$0.80$21.37 million$20.00 millionViewN/AView Earnings Details
8/4/2015Q215$0.54$0.31$20.30 million$19.52 millionViewN/AView Earnings Details
5/5/2015Q115$0.56$0.57$19.86 million$18.80 millionViewN/AView Earnings Details
2/19/2015Q414$0.58$0.67$17.98 million$21.04 millionViewN/AView Earnings Details
11/3/2014Q314$0.46$0.66$14.60 million$17.40 millionViewN/AView Earnings Details
8/4/2014Q214$0.01($0.21)$7.95 million$6.60 millionViewN/AView Earnings Details
5/5/2014Q115$0.32$0.33$11.40 million$10.90 millionViewN/AView Earnings Details
2/27/2014Q414$0.35$5.32 million$10.53 millionViewN/AView Earnings Details
11/7/2013$0.16ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for ANI Pharmaceuticals (NASDAQ:ANIP)
Current Year EPS Consensus Estimate: $3.7 EPS
Next Year EPS Consensus Estimate: $4.23 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.24$0.24$0.24
Q2 20161$0.78$0.78$0.78
Q3 20161$0.94$0.94$0.94
Q4 20161$1.06$1.06$1.06
(Data provided by Zacks Investment Research)


Dividend History for ANI Pharmaceuticals (NASDAQ:ANIP)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for ANI Pharmaceuticals (NASDAQ:ANIP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/22/2016Arthur PrzybylInsiderSell37,455$66.97$2,508,361.35View SEC Filing  
8/8/2016Robert W SchrepferVPSell12,500$67.06$838,250.00View SEC Filing  
12/18/2015James G MarkenVPSell3,500$43.26$151,410.00View SEC Filing  
11/12/2015Arthur PrzybylCEOBuy2,500$40.95$102,375.00View SEC Filing  
3/19/2015James G MarkenVPSell15,000$66.50$997,500.00View SEC Filing  
9/15/2014Ross J ManganoDirectorBuy3,000$27.49$82,470.00View SEC Filing  
9/9/2014Arthur PrzybylCEOBuy1,000$26.50$26,500.00View SEC Filing  
6/18/2014James G MarkenVPSell5,000$34.28$171,400.00View SEC Filing  
5/8/2014Tracy MarshbanksDirectorSell1,381$30.02$41,457.62View SEC Filing  
5/7/2014Ross ManganoDirectorBuy2,000$30.38$60,760.00View SEC Filing  
3/21/2014Tracy MarshbanksDirectorSell21,767$31.42$683,919.14View SEC Filing  
3/20/2014Meridian Venture Partners Ii Lmajor shareholderSell20,922$32.12$672,014.64View SEC Filing  
3/19/2014Tracy MarshbanksDirectorSell25,358$33.68$854,057.44View SEC Filing  
3/18/2014Meridian Venture Partners Ii Lmajor shareholderSell60,540$34.07$2,062,597.80View SEC Filing  
3/13/2014Meridian Venture Partners Ii Lmajor shareholderSell87,723$32.48$2,849,243.04View SEC Filing  
11/7/2013Ross J ManganoDirectorBuy9,000$11.27$101,430.00View SEC Filing  
8/20/2013Ross J ManganoDirectorBuy10,000$7.47$74,700.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for ANI Pharmaceuticals (NASDAQ:ANIP)
DateHeadline logoWill ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Hit $73 Price Target? - Investor Newswire (NASDAQ:ANIP) - August 22 at 8:18 AM logoWhy ANI Pharmaceuticals (ANIP) Could Be Positioned for a Surge? (NASDAQ:ANIP) - August 18 at 11:54 AM logoHow ANI Pharmaceuticals (ANIP) Stock Stands Out in a Strong Industry - Nasdaq (NASDAQ:ANIP) - August 17 at 3:33 PM logoHow ANI Pharmaceuticals (ANIP) Stock Stands Out in a Strong Industry (NASDAQ:ANIP) - August 17 at 11:43 AM logoANI PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K/A) (NASDAQ:ANIP) - August 16 at 8:47 PM logoANI PHARMACEUTICALS INC Files SEC form 8-K/A, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:ANIP) - August 16 at 8:47 PM logoCan The Uptrend Continue for ANI Pharmaceuticals (ANIP)? (NASDAQ:ANIP) - August 16 at 12:07 PM logoMid Cap Unusual Volume: ANI Pharmaceuticals (NASDAQ:ANIP), Copa Holdings (NYSE:CPA), Summit State Bank ... - KC Register (NASDAQ:ANIP) - August 15 at 10:45 AM logoETF’s with exposure to ANI Pharmaceuticals, Inc. : August 15, 2016 (NASDAQ:ANIP) - August 15 at 10:45 AM logo3 Reasons Why ANI Pharmaceuticals (ANIP) is a Great Momentum Stock (NASDAQ:ANIP) - August 12 at 8:59 PM logoANI Pharmaceuticals, Inc. :ANIP-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:ANIP) - August 12 at 3:42 PM logoANI PHARMACEUTICALS INC Financials (NASDAQ:ANIP) - August 12 at 3:42 PM logo3 Reasons Why ANI Pharmaceuticals (ANIP) is a Great Momentum Stock - Yahoo Finance (NASDAQ:ANIP) - August 12 at 12:04 PM logoANI PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:ANIP) - August 11 at 9:23 PM logoGW Pharma (GWPH) Incurs Narrower-than-Expected Q3 Loss (NASDAQ:ANIP) - August 10 at 3:51 PM logoANI Pharmaceuticals Inc. (ANIP) Jumps 6.91% on August 04 - (NASDAQ:ANIP) - August 5 at 8:54 PM logoANI Pharmaceuticals (ANIP) Catches Eye: Stock Jumps 6.9% - Nasdaq (NASDAQ:ANIP) - August 5 at 8:54 PM logoANI Pharmaceuticals (ANIP) Shares March Higher, Can It Continue? (NASDAQ:ANIP) - August 5 at 11:55 AM
News IconANI Pharmaceuticals Reports Record Second Quarter Results and Increases Full-year 2016 Guidance (NASDAQ:ANIP) - August 4 at 12:01 PM logoANI Pharmaceuticals Inc. (ANIP) Has Surged To A New High After Q2 Report (NASDAQ:ANIP) - August 4 at 12:01 PM logoANI beats Street 2Q forecasts (NASDAQ:ANIP) - August 4 at 12:01 PM logoZoetis (ZTS) Beats on Q2 Earnings & Revenues, Lifts Outlook (NASDAQ:ANIP) - August 3 at 12:03 PM logo22nd Century Group (XXII) Catches Eye: Stock Rises 7.8% (NASDAQ:ANIP) - August 2 at 3:31 PM logoCan Cerner (CERN) Spring a Surprise This Earnings Season? (NASDAQ:ANIP) - July 29 at 8:59 PM logoFate Therapeutics (FATE) Catches Eye: Stock Rises 5.9% (NASDAQ:ANIP) - July 29 at 10:02 AM logoEleven Biotherapeutics (EBIO) Jumps: Stock Rises by 10.4% (NASDAQ:ANIP) - July 29 at 8:00 AM logoBioMarin Pharmaceutical (BMRN) Jumps: Stock Rises 6.6% (NASDAQ:ANIP) - July 28 at 12:13 PM logoANI PHARMACEUTICALS INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) (NASDAQ:ANIP) - July 28 at 12:13 PM logoANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter and Year-to-Date 2016 Financial Results (NASDAQ:ANIP) - July 28 at 8:48 AM logoANI PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E (NASDAQ:ANIP) - July 28 at 8:37 AM logoCuris (CRIS) in Focus: Stock Adds 5.7% in Session (NASDAQ:ANIP) - July 27 at 11:44 AM logoIs $68 Price Target Attainable For ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)? - Investor Newswire (NASDAQ:ANIP) - July 25 at 8:17 AM
News IconLasalle Street Capital Management adds ANI Pharmaceuticals Inc (ANIP) to its portfolio - TheFounders Daily (NASDAQ:ANIP) - July 22 at 11:40 AM logoAVEO Pharmaceuticals (AVEO) Catches Eye: Stock Up 10.4% (NASDAQ:ANIP) - July 22 at 8:15 AM logoLigand Pharmaceuticals (LGND) Jumps: Stock Rises 5.5% (NASDAQ:ANIP) - July 21 at 8:25 AM logoANI Pharmaceuticals Inc. (ANIP) is Trading Higher on Unusual Volume for July 19 - (NASDAQ:ANIP) - July 20 at 10:57 PM
News IconTrading Action Review: Watching Unusual Volume on ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - Engelwood Daily (NASDAQ:ANIP) - July 20 at 4:38 PM logoMoody's: FDA Approval of Generic Nilandron is Credit Negative for Concordia; no change to rating or outlook (NASDAQ:ANIP) - July 20 at 10:31 AM logoANI Pharma Announces FDA Approval And Immediate Launch Of Nilutamide Tablets (NASDAQ:ANIP) - July 19 at 8:55 PM
News IconInvestor Watch: Volatility Recap on Shares of: ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - Engelwood Daily (NASDAQ:ANIP) - July 19 at 9:41 AM logoANI Pharma (ANIP) Receives FDA Approval for Nilutamide Tabs ANDA - (NASDAQ:ANIP) - July 19 at 9:41 AM logoANI Pharmaceuticals Gets FDA Approval And Immediate Launch Of Nilutamide Tablets (NASDAQ:ANIP) - July 18 at 1:33 PM logo8:31 am ANI Pharma announces that it has received approval from the FDA for the abbreviated new drug application for nilutamide tablets (NASDAQ:ANIP) - July 18 at 8:31 AM logoANI Pharmaceuticals Announces FDA Approval and Immediate Launch of Nilutamide Tablets, the First Generic Competitor to Nilandron® (NASDAQ:ANIP) - July 18 at 8:30 AM
News IconShare Performance Summary for: ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - Press Telegraph (NASDAQ:ANIP) - July 18 at 8:20 AM
News IconWere Analysts Bullish ANI Pharmaceuticals Inc (NASDAQ:ANIP) This Week? - Consumer Eagle (NASDAQ:ANIP) - July 18 at 8:20 AM
News IconStock in Positive Territory for the Quarter: ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - Engelwood Daily (NASDAQ:ANIP) - July 18 at 8:20 AM logoStrong Sell Calls For ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) At 0 - Investor Newswire (NASDAQ:ANIP) - July 18 at 8:20 AM
News IconReview on Stock Valuation for: ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - TGP (NASDAQ:ANIP) - July 17 at 3:26 PM logoNext Weeks Broker Price Targets For ANI Pharmaceuticals, Inc. (ANIP) - Fiscal Standard (NASDAQ:ANIP) - July 17 at 8:16 AM


ANI Pharmaceuticals (NASDAQ:ANIP) Chart for Wednesday, August, 24, 2016

Last Updated on 8/24/2016 by Staff